Kenneth Lasseter
Clinical Pharmacology · Hialeah, FLNPI 1720255524
Payments from drug & device makers
$4,338,022in general payments, 2019–2025
Across 94 payments — averaging $46,149 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$2.3M
- Ferring Pharmaceuticals AS$1.7M
- Takeda Pharmaceuticals U.S.A., Inc.$120K
- Lexicon Pharmaceuticals, Inc.$55K
- Novo Nordisk AS$35K
- Merck$35K
- plus $115K from 6 others
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 7 | $2,265,538 |
| Ferring Pharmaceuticals AS | 13 | $1,712,670 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $119,803 |
| Lexicon Pharmaceuticals, Inc. | 14 | $55,470 |
| Novo Nordisk AS | 30 | $34,833 |
| Merck | 3 | $34,516 |
| Eli Lilly | 3 | $28,237 |
| AbbVie | 10 | $25,548 |
| Gilead | 2 | $22,976 |
| Bayer | 6 | $17,038 |
| E.r. Squibb & Sons, L.L.C. | 3 | $13,634 |
| Bristol Myers Squibb | 1 | $7,758 |
How this compares
Too few clinical pharmacology providers in Floridato place this figure against a meaningful peer group, so we don't.
Other clinical pharmacology in Hialeah
- Richard PrestonMiami$10.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.